Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis.
Saved in:
| Title: | Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. |
|---|---|
| Authors: | Jung HR; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea., Lee J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Hong SP; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Shin N; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Cho A; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Shin DJ; Medicine Major, Seoul National University College of Medicine, Seoul, Republic of Korea., Choi JW; College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea., Kim JI; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea., Lee JP; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. nephrolee@gmail.com.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea. nephrolee@gmail.com., Cho SY; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea. csybio@snu.ac.kr.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea. csybio@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. csybio@snu.ac.kr. |
| Source: | Experimental & molecular medicine [Exp Mol Med] 2024 Feb; Vol. 56 (2), pp. 355-369. Date of Electronic Publication: 2024 Feb 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2092-6413 (Electronic) Linking ISSN: 12263613 NLM ISO Abbreviation: Exp Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38297163 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting the m<superscript>6</superscript>A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jung+HR%22">Jung HR</searchLink>; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hong+SP%22">Hong SP</searchLink>; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+N%22">Shin N</searchLink>; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Cho+A%22">Cho A</searchLink>; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+DJ%22">Shin DJ</searchLink>; Medicine Major, Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+JW%22">Choi JW</searchLink>; College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JI%22">Kim JI</searchLink>; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JP%22">Lee JP</searchLink>; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. nephrolee@gmail.com.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea. nephrolee@gmail.com.<br /><searchLink fieldCode="AU" term="%22Cho+SY%22">Cho SY</searchLink>; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea. csybio@snu.ac.kr.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea. csybio@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. csybio@snu.ac.kr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229607880%22">Experimental & molecular medicine</searchLink> [Exp Mol Med] 2024 Feb; Vol. 56 (2), pp. 355-369. <i>Date of Electronic Publication: </i>2024 Feb 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9607880 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2092-6413 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2212263613%22">12263613 </searchLink><i>NLM ISO Abbreviation: </i>Exp Mol Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38297163 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s12276-024-01159-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 355 Titles: – TitleFull: Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jung HR – PersonEntity: Name: NameFull: Lee J – PersonEntity: Name: NameFull: Hong SP – PersonEntity: Name: NameFull: Shin N – PersonEntity: Name: NameFull: Cho A – PersonEntity: Name: NameFull: Shin DJ – PersonEntity: Name: NameFull: Choi JW – PersonEntity: Name: NameFull: Kim JI – PersonEntity: Name: NameFull: Lee JP – PersonEntity: Name: NameFull: Cho SY IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2024 Feb Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2092-6413 Numbering: – Type: volume Value: 56 – Type: issue Value: 2 Titles: – TitleFull: Experimental & molecular medicine Type: main |
| ResultId | 1 |